PharmaShots Weekly Snapshots (June 07 – 11, 2021)

 PharmaShots Weekly Snapshots (June 07 – 11, 2021)

Vertex and CRISPR Therapeutics Present New Data of CTX001 from 22 Patients with TDT and SCD at EMA 2021

Published: June 11, 2021 | Tags: Vertex, CRISPR Therapeutics, CTX001, TDT, SCD, EMA 2021

AbbVie Reports Results of Four-Year Follow-Up Analysis in P-III CLL14 Trial for Venclyxto/Venclexta to Treat Chronic Lymphocytic Leukemia

Published: June 11, 2021 | Tags: AbbVie, Four-Year, Follow-Up Analysis, P-III, CLL14 Trial,  Venclyxto, Venclexta, Chronic Lymphocytic Leukemia

Roche Reports New Interim Data of JEWELFISH & RAINBOWFISH Studies for Evrysdi (risdiplam) to Treat Spinal Muscular Atrophy

Published: June 11, 2021 | Tags: Roche, JEWELFISH, RAINBOWFISH, Studies, Evrysdi, risdiplam, Spinal Muscular Atrophy

Verona Pharma Signs $219M Agreement with Nuance Pharma to Develop and Commercialize Ensifentrine in Greater China

Published: June 11, 2021 | Tags: Verona Pharma, $219M, Nuance Pharma, Develop, Commercialize, Ensifentrine, Greater China

BeyondSpring Presents Results of Plinabulin in P-III PROTECTIVE-1 Study for Prevention of Chemotherapy-Induced Neutropenia at ASCO 2021

Published: June 11, 2021 | Tags: BeyondSpring, Plinabulin, P-III, PROTECTIVE-1 Study, Chemotherapy-Induced Neutropenia, ASCO 2021

Gilead’s Epclusa (Sofosbuvir/Velpatasvir) Receives the US FDA’s Approval for Children with Chronic Hepatitis C Infection

Published: June 11, 2021 | Tags: Gilead, Epclusa, Sofosbuvir, Velpatasvir, US, FDA, Approval,  Chronic Hepatitis C Infection

Takeda Expands its License Agreement with Codexis to Discover Novel Gene Therapies for Fourth Rare Genetic Disorders

Published: June 10, 2021 | Tags: Takeda, License Agreement, Codexis, Novel Gene Therapies, Rare Genetic Disorders

BeiGene Signs an Exclusive Worldwide Collaboration with Shoreline to Develop and Commercialize Genetically Modified NK Cell Therapies

Published: June 10, 2021 | Tags: BeiGene, Shoreline, Develop, Commercialize, Genetically Modified NK Cell Therapies

Vertex’s Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) Receives the US FDA’s Approval in Children Aged 6 to 11 with Certain Mutations in Cystic Fibrosis

Published: June 10, 2021 | Tags: Vertex, Trikafta, elexacaftor, tezacaftor, ivacaftor, US, FDA, Approval, Cystic Fibrosis

Hummingbird Collaborates with Novogene to Expand Precision Therapy Testing for NRG1-Fusion Driven Cancers in China

Published: June 10, 2021 | Tags: Hummingbird, Novogene, Precision Therapy Testing, NRG1-Fusion Driven Cancers, China

Inovio Expands its Partnership with Advaccine to Initiate P-III Efficacy Trial for INO-4800 to Treat COVID-19

Published: June 10, 2021 | Tags: Inovio, Advaccine, P-III, Efficacy Trial, INO-4800, COVID-19

Merck Signs ~$1.2B Supply Agreement with US Government for Molnupiravir to Treat COVID-19

Published: June 10, 2021 | Tags: Merck, ~$1.2B, Supply Agreement, US Government, Molnupiravir, COVID-19

AbbVie Collaborates with Caraway to Develop TMEM175 for Parkinson’s Disease and Other Related Disorders

Published: June 9, 2021 | Tags: AbbVie, Caraway, Develop, TMEM175, Parkinson’s Disease, Related Disorders

Bio-Thera Reports the Initiation of P-III Clinical Trial for BAT2506 (biosimilar, golimumab)

Published: June 9, 2021 | Tags: Bio-Thera, P-III, Clinical Trial, BAT2506, biosimilar, golimumab

Cardiff Oncology Reports First Patient Dosing in P-II Trial for Onvansertib + Irinotecan and 5-FU as a 2L Treatment for Metastatic Pancreatic Ductal Adenocarcinoma

Published: June 9, 2021 | Tags: Cardiff Oncology, P-II, Trial, Onvansertib, Irinotecan, 5-FU, Metastatic Pancreatic Ductal Adenocarcinoma

Pfizer’s Prevnar 20 (Pneumococcal 20-Valent Conjugate Vaccine) Receives the US FDA’s Approval for the Prevention of Invasive Disease and Pneumonia

Published: June 9, 2021 | Tags: Pfizer, Prevnar 20, Pneumococcal 20-Valent Conjugate Vaccine, US, FDA, Approval, Invasive Disease, Pneumonia

Progentec Signs a Research Collaboration with GSK to Evaluate Proteomics and Digital Health Tools for SLE

Published: June 9, 2021 | Tags: Progentec, GSK, Proteomics, Digital Health Tools, SLE

Bayer to Advance its Investigational Cell and Gene Therapy for Parkinson’s Disease

Published: June 9, 2021 | Tags: Bayer, Cell Therapy, Gene Therapy, Parkinson’s Disease

AbbVie’s Rinvoq (upadacitinib) Receives the Health Canada’s Approval for the Treatment of Psoriatic Arthritis

Published: June 8, 2021 | Tags: AbbVie, Rinvoq, upadacitinib, Health Canada, Approval, Psoriatic Arthritis

BeiGene Reports NMPA’s Acceptance of sBLA for Tislelizumab to Treat MSI-H or dMMR Solid Tumors

Published: June 8, 2021 | Tags: BeiGene, NMPA, sBLA, Tislelizumab, MSI-H, dMMR Solid Tumors

Roche’s SARS-CoV-2 Antigen Test Receives CE mark For Self Testing of COVID-19 at Home

Published: June 8, 2021 | Tags: Roche, SARS-CoV-2 Antigen Test, CE mark, Self Testing, COVID-19

Janssen Discontinues its 2018 License Agreement with Argenx for Cusatuzumab

Published: June 8, 2021 | Tags: Janssen, Discontinues, 2018, License Agreement, Argenx, Cusatuzumab

MSD Animal Health Acquires LICA’s Assets to Enhance its Dairy Farm Management Solutions

Published: June 8, 2021 | Tags: MSD Animal Health, Acquires, LICA Assets, Dairy Farm Management Solutions

Biogen and Eisai’s Aduhelm (aducanumab-avwa) Receive the US FDA’s Accelerated Approval for Alzheimer Disease

Published: June 8, 2021 | Tags: Biogen, Eisai, Aduhelm, aducanumab-avwa, US, FDA, Accelerated Approval, Alzheimer Disease

SpringWorks and Seagen Enter into a Clinical Collaboration to Evaluate Nirogacestat + SEA-BCMA for R/R Multiple Myeloma

Published: June 7, 2021 | Tags: SpringWorks, Seagen, Nirogacestat, SEA-BCMA, R/R Multiple Myeloma

AstraZeneca Reports Updated Results of Imfinzi (durvalumab) in P-III PACIFIC Trial for Non-Small Cell Lung Cancer

Published: June 7, 2021 | Tags: AstraZeneca, Imfinzi, durvalumab, P-III, PACIFIC Trial, Non-Small Cell Lung Cancer

AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III Head-to-Head ELEVATE-RR Trial for Chronic Lymphocytic Leukemia

Published: June 7, 2021 | Tags: AstraZeneca, Calquence, acalabrutinib, P-III, Head-to-Head ELEVATE-RR Trial, Chronic Lymphocytic Leukemia

Novo Nordisk’s Wegovy (semaglutide, 2.4mg) Receives the US FDA’s Approval for Weight Management in Adults with Obesity

Published: June 7, 2021 | Tags: Novo Nordisk, Wegovy, semaglutide, US, FDA, Approval, Weight Management, Obesity

ProMetic’ Ryplazim (plasminogen) Receives the US FDA’s Approval as First Treatment for Patients with Plasminogen Deficiency

Published: June 7, 2021 | Tags: ProMetic, Ryplazim, plasminogen, US, FDA, Approval, Plasminogen Deficiency

Novartis Presents Results of Iptacopan in P-II Study for IgA Nephropathy at ERA-EDTA Congress

Published: June 7, 2021 | Tags: Novartis, Iptacopan, P-II, Study, IgA Nephropathy, ERA-EDTA Congress

Related Post: PharmaShots Weekly Snapshots (May 31 – June 4, 2021)

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post